Michael Rapp, 10% Owner at Zynerba Pharmaceuticals, Inc. (ZYNE), bought 11,770 shares at $10.45 ($123K) on 2018-05-30, disclosed to the SEC on 2018-05-31.
Open-market purchase of $123k ZYNE by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.45 | 5,885 | $61K | 50.0% |
| 2 | $10.45 | 5,885 | $61K | 50.0% |
| Total | $10.45 avg | 11,770 | $123K | 100% |
| Filing → |
| IMNM | BUY | 2021-05-26 | $1.9M | — | Filing → |
| IMNM | BUY | 2020-10-08 | $1000K | — | Filing → |
| ZYNE | BUY | 2018-05-02 | $157K | — | Filing → |